Gene · 6510
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting METTL3 induces a metabolic vulnerability in ER+ breast carcinoma cells. | Endocr Relat Cancer | 2025 | 41293999 | PubTator, text mining | PubMed |
| Self-Assembly Albumin Nanoparticles for Improved Anticancer Effect and Reinforced Ferroptosis in Metastatic Colorectal Cancer Treatment. | ACS Appl Mater Interfaces | 2025 | 41289587 | PubTator, text mining | PubMed |
| MRI of ASCT2-mediated amino acid uptake in xenograft tumor models. | Res Sq | 2025 | 41282145 | PubTator, text mining | PubMed |
| Fibulin7 C-terminal bioactive peptide regulates metabolic profiling of macrophages during inflammation via integrin α5β1. | Biochem Biophys Res Commun | 2025 | 41270488 | PubTator, text mining | PubMed |
| Astatine-211-Labeled Therapy Targeting Amino Acid Transporters: Overcoming Drug Resistance in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2025 | 41226775 | PubTator, text mining | PubMed |
| Elevated SLC1A5 links to inflamed endothelial cells and proteinuria in membranous nephropathy patients. | PeerJ | 2025 | 41189572 | PubTator, text mining | PubMed |
| Variations in blood levels of the anti-fusogenic endogenous retroviral protein suppressyn are associated with fetal growth outcome in preeclampsia. | Sci Rep | 2025 | 41184406 | PubTator, text mining | PubMed |
| SLAMF7 promotes TCRαβ+ double negative T cell antitumor activity through enhancing glutamine metabolism. | J Exp Clin Cancer Res | 2025 | 41168829 | PubTator, text mining | PubMed |
| Unveiling Metabolic Signatures as Potential Biomarkers in Common Cancers: Insights from Lung, Breast, Colorectal, Liver, and Gastric Tumours. | Biomolecules | 2025 | 41154605 | PubTator, text mining | PubMed |
| Identification of biomarkers and therapeutic targets of schizophrenia using glutamine metabolism. | Asian J Psychiatr | 2025 | 41151350 | PubTator, text mining | PubMed |
| From intracellular drivers to immune modulators: emerging paradigms in oncogenic pathway-directed immunotherapy optimization. | Cell Commun Signal | 2025 | 41126244 | PubTator, text mining | PubMed |
| CircRBM33 facilitates colorectal cancer progression by regulating the miR-512-5p/SLC1A5 axis. | Pathol Res Pract | 2025 | 41086588 | PubTator, text mining | PubMed |
| The influence of ferroptosis-associated gene HSPA5 on the prognosis and immune evasion of lung adenocarcinoma. | Discov Oncol | 2025 | 41085902 | PubTator, text mining | PubMed |
| Inhibition of integrin α3 suppresses gastric cancer progression via STAT3-mediated regulation of SLC1A5-dependent glutamine uptake. | J Gastroenterol | 2025 | 41060436 | PubTator, text mining | PubMed |
| ZKSCAN5 transcriptional regulation of APOC1 modulates ferroptosis via PI3K/AKT/SREBP2/SLC1A5 axis. | J Transl Med | 2025 | 41029397 | PubTator, text mining | PubMed |
| Genetic variations in amino acid metabolism-related genes are associated with risk of papillary thyroid carcinoma: a case-control study. | BMC Endocr Disord | 2025 | 41029308 | PubTator, text mining | PubMed |
| Research Advances of the Effects of Food and Medicine Homology Substances on Gastric Cancer. | Cancer Med | 2025 | 41020681 | PubTator, text mining | PubMed |
| Engineering Universal Cancer Immunity: Non-Tumor-Specific mRNA Vaccines Trigger Epitope Spreading in Cold Tumors. | Vaccines (Basel) | 2025 | 41012173 | PubTator, text mining | PubMed |
| Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications. | J Pers Med | 2025 | 41003134 | PubTator, text mining | PubMed |
| Triclabendazole inhibits PKM2 nuclear localization and glycolysis by enhancing HDAC6-mediated deacetylation in lung cancer. | J Transl Med | 2025 | 40993625 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6510/papers?page=7